セッション情報

FACO International Workshop

第53回・2015年・京都
FACO International Workshop
FACO International Workshop 9
Novel Immunotherapy and Chemothnorty
開催回
第53回・2015年・京都

A phase 1/2 study of multiple peptides cocktail vaccine for treatment- resistant cervical and ovarian cancer

演題番号 : FWS9-1

Takeuchi Satoshi:1、Shoji Tadahiro:1、Kagabu Masahiro:1、Honda Tatsuya:1、Kojima Atsumi:1、Nitta Yukari:1、Sugiyama Toru:1、Nakamura Yusuke:2

1:Obstetrics and Gynecology, Iwate Medical University、2:Chicago University

A phase 1/2 study of multiple peptides cocktail vaccine for treatment- resistant cervical and ovarian cancer

A phase I/II study of endoscopic intratumoral administration of a telomerase targeted oncolytic virus, OBP-301, in combination with radiotherapy for esophageal cancer

演題番号 : FWS9-2

Kagawa Shunsuke:1,2、Tanabe Shunsuke:1,3、Tazawa Hiroshi:1,3、Noma Kazuhiro:1、Koujima Takeshi:1、Kashima Hajime:1、Kato Takuya:1、Kuroda Shinji:1、Kikuchi Satoru:1、Shirakawa Yasuhiro:1、Fujiwara Toshiyoshi:1

1:Department of Gastroenterology, Graduate School of Medicine,Dentistry and Pharmaceutical Sciences, Okayama University、2:Minimally Invasive Therapy Center, Hospital, Okayama University、3:Center for Innovative Clinical Medicine, Hospital, Okayama University

A phase I/II study of endoscopic intratumoral administration of a telomerase targeted oncolytic virus, OBP-301, in combination with radiotherapy for esophageal cancer

The possibility of biological ablation of lymphatic metastasis for early gastrointestinal cancer patients

演題番号 : FWS9-3

Kikuchi Satoru:1、Kishimoto Hiroyuki:1、Tazawa Hiroshi:2、Kuroda Shinji:1、Nishizaki Masahiko:1、Kagawa Shunsuke:1、Urata Yasuo:3、M. Hoffman Robert:4、Fujiwara Toshiyoshi:1

1:Gastroenterological surgery, Graduate School of Medicine,Dentistry and Pharmaceutical Sciences, Okayama University、2:Center for innovative clinical medicine, Hospital, Okayama University、3:Oncolys BioPharma Inc.、4:Surgery, University of California, San Diego

The possibility of biological ablation of lymphatic metastasis for early gastrointestinal cancer patients

Clinical adaptaion of CRM197, EGFR ligand inhibitors, in mono and combination therapy with cetuximab for head and neck cancers

演題番号 : FWS9-4

Hatakeyama Hiromitsu:1、Kano Satoshi:1、Mizumachi Takatsugu:1、Sakashita Tomohiro:1、Homma Akihiro:1、Fukuda Satoshi:1

1:Otolaryngology Head and Neck Surgery, Graduate School of Medicine, Hokkaido University

Clinical adaptaion of CRM197, EGFR ligand inhibitors, in mono and combination therapy with cetuximab for head and neck cancers

Immunological mechanisms of cancer cachexia in patients with solid tumors

演題番号 : FWS9-5

Shibata Masahiko:1,2,3、Gonda Kenji:1、Shimura Tatsuo:2,3、Nakajima Takahiro:3、Nakamura Izumi:3、Ohki Shinji:3、Otake Toru:3、Kono Koji:3、Suzuki Shinichi:3、Takenoshita Seiichi:3

1:Department of gastroenterological Oncology, International Medical Center, Saitama Medical University、2:Tumor and Host Bioscience, Fukushima Medical University、3:Organ Regulatory Surgery, Fukushima Medical University

Immunological mechanisms of cancer cachexia in patients with solid tumors